Clinuvel Pharmaceuticals Limited (ASX:CUV – Get Free Report) insider Philippe Wolgen acquired 1,850 shares of the firm’s stock in a transaction that occurred on Tuesday, September 19th. The shares were purchased at an average price of A$16.12 ($10.40) per share, with a total value of A$29,812.75 ($19,234.03). Philippe Wolgen also recently made the following trade(s): […]